FDA
-
New Experimental Drug at Quakertown Veterinary Clinic Aims to Extend Dogs’ Lives
A new experimental drug offered at Quakertown Veterinary Clinic aims to help dogs live longer and have better lives, report Stephanie Stahl and Nate Sylves…
-
With FDA Decision Looming, Plymouth Meeting’s Inovio Cuts Workforce to Preserve Cash
Over the past year, Plymouth Meeting-based Inovio Pharmaceuticals has reduced its workforce by 16 percent to preserve cash as it waits for the Food and…
-
Plymouth Meeting Pharmaceutical Company Eyes $1B Milestone
Harmony Biosciences says its flagship narcolepsy drug is on track to hit a major milestone, writes John George for The Philadelphia Business Journal. The Plymouth…
-
First-of-Its-Kind Dry Eye Treatment Spa Comes to Bryn Mawr
A new kind of eye care has arrived on the Main Line, blending medical treatment with spa-style rejuvenation, writes Timothy Alexander for MyChesCo. See La…
-
Bensalem Man Regains Mobility After Injury Thanks to Experimental Drug
Larry Williams, a Bensalem resident left paralyzed after a cycling accident three years ago, has regained the ability to walk with the help of an…
-
Merck Finalizes $10 Billion Acquisition, Expands COPD Treatment Portfolio
Pharmaceutical giant Merck, which maintains major operations in Montgomery County, has completed its $10 billion acquisition of Verona Pharma, writes the New Jersey Business and…
-
King of Prussia’s SEED Therapeutics Pioneers “Molecular Glue” Cancer Treatments
King of Prussia’s SEED Therapeutics is tackling one of medicine’s toughest challenges, writes Holly Quinn for Technical.ly. The biotech startup is treating diseases driven by…
-
Conshohocken’s ActiveProtective Launches Tango Belt, Eyes Nationwide Expansion
Conshohocken-based ActiveProtective has launched the Tango Belt, a fall prevention device that has been approved by the Food and Drug Administration, writes John George for…
-
West Conshohocken’s Madrigal Pharmaceuticals Gets FDA Green Light
West Conshohocken’s Madrigal Pharmaceuticals earned a major win with the FDA approval of its first commercial product, reports John George for the Philadelphia Business Journal.…
-
Glaxosmithkline Gets Approval for First-of-its-Kind Lupus Treatment
Glaxosmithkline, with multiple operations in Montco, just scored a major regulatory win that could reshape how lupus nephritis is treated in children, writes Neha Gupta…
-
FDA Denies Langhorne-Based Savara Application for Rare Lung Disease Treatment
The Food and Drug Administration has rejected an application filed by Langhorne-based Savara for its new drug candidate Molbreevi as a treatment for rare lung…
-
Doylestown Surgeons Pioneer Dissolvable Stents for Clearing Blocked Leg Arteries
Vascular surgeons at Doylestown Hospital have pioneered a dissolvable stent that holds clogged arteries open long enough to heal, according to a staff report from…
-
Warrington-Based Windtree Therapeutics Buys Huston Apartment Complex
Warrington-based Windtree Therapeutics is purchasing a 436-unit apartment complex in Texas as part of its strategy to generate revenue while continuing with the development of…
-
Synthetic Dye Ban Puts Philadelphia’s Classic Treats at Risk
With the Department of Health and Human Services, led by Robert F. Kennedy Jr., moving to phase out eight petroleum-based artificial food dyes, several iconic…
-
After Fielding Multiple Offers, Yardley-Based Optinose Secures Potential $330M Deal With Paratek
Yardley-based Optinose, which put itself up for auction three years ago attracting multiple suitors, has secured a potential $330 million deal with Paratek, writes John…
-
Warrington’s Windtree Therapeutics Eyes Acquisitions to Stay Afloat
To remain viable, Warrington-based Windtree Therapeutics plans on boosting revenue by acquiring smaller companies with FDA-approved products, writes John George for the Philadelphia Business Journal.…
-
Bala Cynwyd-Based Larimar Therapeutics Chosen for FDA’s START Pilot Program
The Food and Drug Administration has selected Bala Cynwyd-based Larimar Therapeutics’ lead drug candidate for its new program inspired by the Operation Warp Speed initiative,…
-
Wall Street Journal: University City-based BioTech Firm Nears Human Trials for Breakthrough Artificial Womb Technology
University City-based Vitara Biomedical is currently working on an artificial womb for premature babies and is getting closer to human clinical trials, writes Liz Essley…
Founding Partners
Advertisement
Affiliate Partners
